Aqueous cinnamon extract ameliorates bowel dysfunction and enteric 5-HT synthesis in IBS rats
Frontiers in Pharmacology · 09.01.2023 · 13
DOI: 10.3389/fphar.2022.1010484 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 09.01.2023. Verfasst von Lijuan Yu und 13 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Medicine, Hong Kong Baptist University, Hong Kong SAR, China. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Health and Medical Research Fund, Special Project for Research and Development in Key Areas of Guangdong Province.
Abstract (Originalsprache)
Cinnamon protects against irritable bowel syndrome with diarrhea (IBS-D) in humans, but its efficacy and underlying mechanism of action remain poorly understood. Maternally separated (MS) IBS-D rat model and 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced post-inflammatory IBS-D rat model are characterized by visceral hyperalgesia and diarrhea. This study used the two models to evaluate the effect of cinnamon extract (CE) on bowel symptoms. The MS rat model was also used to explore its underlying anti-IBS mechanism. cinnamon extract reduced defecation frequency and visceral hyperalgesia in MS rats in a dose-dependent manner and effectively improved visceral hyperalgesia in TNBS rats. The efficacy of cinnamon extract was comparable to the positive drug serotonin receptor 3 (5-HT3) selective antagonist, Ramosetron. Excessive 5-HT, a well-known pathogenic factor for IBS, in the colon and circulation of IBS rats was reduced after cinnamon extract intervention. Both, gene and protein levels of the colonic 5-HT synthetase, Tryptophan Hydroxylase 1 (Tph1), were also decreased in CE-treated IBS rats. In addition, a luciferase assay revealed that cinnamon extract and its major components, catechin, procyanidin B1/2, cinnamic acid, and cinnamyl alcohol, significantly inhibited Tph1 transcription activity in vitro . These findings illustrated that aqueous cinnamon extract partially attenuated bowel symptoms in IBS models by directly inhibiting Tph1 expression and controlling 5-HT synthesis. This provides a scientific viewpoint for the use of cinnamon as a folk medication to treat IBS.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Chinese Medicine, Hong Kong Baptist University, Hong Kong SAR, China.
- College of Basic Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China.
- Centre for Chinese Herbal Medicine Drug Development Limited, Hong Kong Baptist University, Hong Kong SAR, China.
- Center for Translational Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
- Academy of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Förderung
- National Natural Science Foundation of China
- Health and Medical Research Fund
- Special Project for Research and Development in Key Areas of Guangdong Province
Zitieren
APA
Yu, L., Huang, C., Yang, W., Ren, Z., Li, L., Cheng, H., Lin, C., Zhai, L., Ning, Z., Wong, H. X., Han, Q., Jia, W., Bian, Z., & Zhao, L. (2023). Aqueous cinnamon extract ameliorates bowel dysfunction and enteric 5-HT synthesis in IBS rats. Frontiers in Pharmacology, 13. https://doi.org/10.3389/fphar.2022.1010484
Vancouver
Yu L, Huang C, Yang W, Ren Z, Li L, Cheng H, et al. Aqueous cinnamon extract ameliorates bowel dysfunction and enteric 5-HT synthesis in IBS rats. Frontiers in Pharmacology. 2023;13. doi:10.3389/fphar.2022.1010484
BibTeX
@article{Yu2023,
author = {Yu, Lijuan and Huang, Chunhua and Yang, Wei and Ren, Zhenxing and Li, Lifeng and Cheng, Huiyuan and Lin, Chengyuan and Zhai, Lixiang and Ning, Ziwan and Wong, Hoileong Xavier and Han, Quanbin and Jia, Wei and Bian, Zhaoxiang and Zhao, Ling},
title = {Aqueous cinnamon extract ameliorates bowel dysfunction and enteric 5-HT synthesis in IBS rats},
journal = {Frontiers in Pharmacology},
year = {2023},
volume = {13},
doi = {10.3389/fphar.2022.1010484}
}
EUVIMED